The fetal cerebroplacental ratio in pregnancies complicated by hypertensive disorders of pregnancy.


Journal

The Australian & New Zealand journal of obstetrics & gynaecology
ISSN: 1479-828X
Titre abrégé: Aust N Z J Obstet Gynaecol
Pays: Australia
ID NLM: 0001027

Informations de publication

Date de publication:
12 2021
Historique:
received: 27 02 2021
accepted: 20 05 2021
pubmed: 20 7 2021
medline: 15 12 2021
entrez: 19 7 2021
Statut: ppublish

Résumé

Hypertensive disorder in pregnancy is common and the optimal ultrasound surveillance of the fetus in this setting is unclear. The aim of this study is to assess the relationship between the fetal cerebroplacental ratio (CPR) and perinatal outcomes in pregnancies complicated by maternal hypertension. A retrospective cohort study was performed over ten years at a single centre. All women who had an ultrasound scan between 34 and 37 weeks gestation with a non-anomalous singleton pregnancy were included. The hypertensive cohorts were compared to a non-hypertensive cohort. Each cohort was divided into low CPR for gestational age, or normal/high CPR and these were correlated with intrapartum and perinatal outcomes. A low CPR in a hypertensive pregnancy is associated with an increased risk of induction of labour, emergency caesarean section and poor perinatal outcome. This significance persists when adjusted for gestational age and birth weight. The diagnosis of pre-eclampsia combined with a low CPR markedly increases the risk of poor perinatal outcome, with 52.6% (P < 0.001) of fetuses in this group having either neonatal intensive care unit admission, respiratory distress, low Apgar score, or acidosis. The odds ratio of a fetus with low CPR in a woman with pre-eclampsia having a poor composite outcome is 4.09 (95% CI: 1.85-9.06). There is an association between low CPR and the perinatal outcomes of pregnancies complicated by a hypertensive disorder. This association appears to be stronger in pregnancies complicated by pre-eclampsia than in other types of hypertensive disorders.

Sections du résumé

BACKGROUND
Hypertensive disorder in pregnancy is common and the optimal ultrasound surveillance of the fetus in this setting is unclear.
AIM
The aim of this study is to assess the relationship between the fetal cerebroplacental ratio (CPR) and perinatal outcomes in pregnancies complicated by maternal hypertension.
MATERIALS AND METHODS
A retrospective cohort study was performed over ten years at a single centre. All women who had an ultrasound scan between 34 and 37 weeks gestation with a non-anomalous singleton pregnancy were included. The hypertensive cohorts were compared to a non-hypertensive cohort. Each cohort was divided into low CPR for gestational age, or normal/high CPR and these were correlated with intrapartum and perinatal outcomes.
RESULTS
A low CPR in a hypertensive pregnancy is associated with an increased risk of induction of labour, emergency caesarean section and poor perinatal outcome. This significance persists when adjusted for gestational age and birth weight. The diagnosis of pre-eclampsia combined with a low CPR markedly increases the risk of poor perinatal outcome, with 52.6% (P < 0.001) of fetuses in this group having either neonatal intensive care unit admission, respiratory distress, low Apgar score, or acidosis. The odds ratio of a fetus with low CPR in a woman with pre-eclampsia having a poor composite outcome is 4.09 (95% CI: 1.85-9.06).
CONCLUSION
There is an association between low CPR and the perinatal outcomes of pregnancies complicated by a hypertensive disorder. This association appears to be stronger in pregnancies complicated by pre-eclampsia than in other types of hypertensive disorders.

Identifiants

pubmed: 34278557
doi: 10.1111/ajo.13400
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

898-904

Informations de copyright

© 2021 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists.

Références

Lowe SA, Bowyer L, Lust K et al. The SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014. Aust N Z J Obstet Gynaecol 2015; 55(1): 11-16.
Abalos E, Cuesta C, Carroli G et al. Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization multicountry survey on maternal and newborn health. BJOG 2014; 121(Suppl 1): 14-24.
Prior T, Mullins E, Bennett P et al. Prediction of intrapartum fetal compromise using the cerebroumbilical ratio: a prospective observational study. Am J Obstet Gynecol 2013; 208(2): 124.e1-6.
Morales-Roselló J, Khalil A, Morlando M et al. Changes in fetal Doppler indices as a marker of failure to reach growth potential at term. Ultrasound Obstet Gynecol 2014; 43: 303-310.
Prior T, Paramasivam G, Bennett P, Kumar S. Are fetuses that fail to achieve their growth potential at increased risk of intrapartum compromise? Ultrasound Obstet Gynecol 2015; 46: 460-464.
Khalil AA, Morales-Rosello J, Morlando M et al. Is fetal cerebroplacental ratio an independent predictor of intrapartum fetal compromise and neonatal unit admission? Am J Obstet Gynecol 2015; 213(1): 54.e1-54.e10.
Khalil AA, Morales-Rosello J, Elsaddig M et al. The association between fetal Doppler and admission to neonatal unit at term. Am J Obstet Gynecol 2015; 213(1): 57.e1-57.e7.
Sabdia S, Greer RM, Prior T, Kumar S. Predicting intrapartum fetal compromise using the fetal cerebro-umbilical ratio. Placenta 2015; 36: 594-598.
Khalil A, Morales-Roselló J, Townsend R et al. Value of third-trimester cerebroplacental ratio and uterine artery Doppler indices as predictors of stillbirth and perinatal loss. Ultrasound Obstet Gynecol 2016; 47(1): 74-80.
Severi FM, Bocchi C, Visentin A et al. Uterine and fetal cerebral Doppler predict the outcome of third-trimester small-for-gestational age fetuses with normal umbilical artery Doppler. Ultrasound Obstet Gynecol 2002; 19(3): 225-228.
Cruz-Martinez R, Figueras F, Oros D et al. Cerebral blood perfusion and neurobehavioral performance in full-term small-for-gestational-age fetuses. Am J Obstet Gynecol 2009; 201: 474.e1-7.
Figueras F, Savchev S, Triunfo S et al. An integrated model with classification criteria to predict small-for-gestational-age fetuses at risk of adverse perinatal outcome. Ultrasound Obstet Gynecol 2015; 45(3): 279-285.
Dunn L, Sherrell H, Kumar S. Review: Systematic review of the utility of the fetal cerebroplacental ratio measured at term for the prediction of adverse perinatal outcome. Placenta 2017; 54: 68-75.
Zingler E, Syngelaki A, Nicolaides K, et al. Routine assessment of cerebroplacental ratio at 35-37 weeks’ gestation in the prediction of adverse perinatal outcome. Am J Obstet Gynecol. 2019; 221: 65.e1-65.e18.
Bligh LN, Al Solai A, Greer RM et al. Diagnostic performance of cerebroplacental ratio thresholds at term for prediction of low birthweight and adverse intrapartum and neonatal outcomes in a term, low-risk population. Fetal Diagn Ther 2018; 43(3): 191-198.
Regan J, Masters H, Warshak CR. Association between an abnormal cerebroplacental ratio and the development of severe pre-eclampsia. J Perinatol 2015; 35: 322-327.
Adiga P, Kantharaja I, Rai L et al. Predictive Value of Middle Cerebral Artery to Uterine Artery Pulsatility Index Ratio in Hypertensive Disorders of Pregnancy. Int J Reprod Med. 2015; 2015: 1-5.
Bligh LN, Alsolai AA, Greer RM et al. Cerebroplacental ratio thresholds measured within 2 weeks before birth and risk of Cesarean section for intrapartum fetal compromise and adverse neonatal outcome. Ultrasound Obstet Gynecol 2018; 52: 340-346.
DeVore GR. The importance of the cerebroplacental ratio in the evaluation of fetal well-being in SGA and AGA fetuses. Am J Obstet Gynecol 2015; 213(1): 5-15.
Sherrell HC, Clifton VL, Kumar S. Prelabor screening at term using the cerebroplacental ratio and placental growth factor: a pragmatic randomized open-label phase 2 trial. Am J Obstet Gynecol 2020; 223(3): 429.e1-429.e9.
Kumar S, Figueras F, Ganzevoort W et al. Using cerebroplacental ratio in non-SGA fetuses to predict adverse perinatal outcome: caution is required. Ultrasound Obstet Gynecol 2018; 52: 427-429.

Auteurs

Jade Lodge (J)

Women's Ultrasound and Maternal Fetal Medicine, Wellington Hospital, Wellington, New Zealand.
Centre for Maternal and Fetal Medicine, Mater Mother's Hospital, Brisbane, Queensland, Australia.

Christopher Flatley (C)

Mater Research Institute, University of Queensland, Brisbane, Queensland, Australia.

Sailesh Kumar (S)

Centre for Maternal and Fetal Medicine, Mater Mother's Hospital, Brisbane, Queensland, Australia.
Mater Research Institute, University of Queensland, Brisbane, Queensland, Australia.
Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH